Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloperidone augmentation for residual anger in MDD
NCT01464229Phase 4Completed
- Sponsor
- Maurizio Fava
- Start
- Apr 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iloperidone in major depressive disorder (MDD), sponsored by Maurizio Fava. Started Apr 2012; status: completed.
02
Drugs
iloperidone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01464229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464229.